Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
BD Names First CRO To Drive Commercial Overhaul As ’New BD‘ Strategy Builds Toward 2026 Launch
Mike Feld To Unify Commercial Execution And Drive BD Excellence Principles Across Revenue Operations.
Nov 13 2025
•
By
Shubham Singh
The company is increasing its commercial investment by about $30m above the normal run rate of $400 m to $450 m, targeting high-growth and high-margin markets. Picture Courtesy: Shutterstock
More from Strategy
More from Business